Clozapine audit: What do patients and relatives think?

Journal of Mental Health

Volumn 5, Issue 3, 1996, Pages 267-274

  Wolfson, Paul Martin ^a   Paton, Carol ^a  

^a Bexley Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DROWSINESS; DRUG COST; FAMILY; FEMALE; HUMAN; HYPERSALIVATION; MALE; NEUTROPENIA; PATIENT ATTITUDE; SCHIZOPHRENIA; SEIZURE;

EID: 0029901827     PISSN: 09638237     EISSN: None     Source Type: Journal    
DOI: 10.1080/09638239650036938     Document Type: Article

References (11)

1. Addington, D., Addington. J. & Maticka-Tyndale. E. (1993). Assessing Depression in Schizophrenia; The Calgary Depression Scale. British Journal of Psychiatry. 163, 39-44.
2. Awad. A.G. (1993). Subjective Response to Neuroleptics in Schizophrenia. Schizophrenia Bulletin. 19, 609-617.
3. The Clozaril Patient Monitoring Service;.A Summary of its Operation and Scope. Sandoz Pharmaceuticals (1993).
4. Guy. W. (1976). The Clinical Global Impression Scale. ECDEU Assessment Manual for Psychopharmacology, revised DHEW pub no (ADM) 78-388, Rockville, M.D.; National Institute of Mental Health.
5. Kane. J.M. (1992). Clinical Efficacy of Clozapine in Treatment-Refractory Schizophrenia - An Overview. British Journal of Psychiatry, 160, 41-45.
6. Kerwin. R.W. (1994). The New Atypical Antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research. British Journal of Psychiatry, 164, 141-148.
7. Krupp. P. & Barnes. P. (1992). Clozapine-Associated Agranulocytosis; Risk and Aetiology. British Journal of Psychiatry. 160, 38-40.
8. Matheson. L.A., Cook. H.M., McKenna. P. & Bosannquel, N. (1994). Value for money care for patients with schizophrenia.British Journal of Medical Economics, 7, 25-34.
9. Meltzer. H.Y. (1992). Dimensions of Outcome with Clozapine. British Journal of Psychiatry, 160, 46-53.
10. Overall. J.E. & Gorham. D.R. (1962). The Brief Psychiatric Rating Scale. Psychological Reports, 10, 799-812.
11. Weiden. P, Rapkin. B, Mott. T, Zygmunt, A., Goldman, D., Horvitz-Lennon, M & Frances. A. (1994). Rating of Medication Influences (ROMI) Scale in Schizophrenia. Schizophrenia Bulletin, 20, 297-309.